Healthcare Sector

ABBV

Market Tracker

  • ABBV (Selected)

    AbbVie Inc.

ABBV Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

ABBV Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

ABBV Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

ABBV Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
09/18/2026 CALL $250.00 1,397 +976 +231.83%
04/17/2026 CALL $240.00 3,364 +709 +26.70%
04/17/2026 PUT $170.00 630 +600 +2,000.00%
04/17/2026 PUT $220.00 1,073 +393 +57.79%
06/18/2026 PUT $200.00 2,573 +289 +12.65%
04/02/2026 CALL $220.00 287 +238 +485.71%
03/20/2026 PUT $240.00 21 -63 -75.00%
04/17/2026 CALL $250.00 1,783 -66 -3.57%
03/20/2026 PUT $220.00 3,500 -114 -3.15%
03/20/2026 PUT $210.00 3,611 -116 -3.11%
03/20/2026 CALL $227.50 486 -200 -29.15%
03/20/2026 CALL $240.00 9,635 -205 -2.08%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

ABBV Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.05% 53.76M 7.26B
Vanguard 500 Index Fund 2.32% 40.88M 5.52B
Fidelity 500 Index Fund 1.10% 19.39M 2.62B
SPDR S&P 500 ETF Trust 1.09% 19.15M 2.58B
American Mutual Fund Inc 1.00% 17.6M 2.38B
iShares Core S&P 500 ETF 0.89% 15.78M 2.13B
Vanguard Index-Value Index Fund 0.87% 15.28M 2.06B
Capital Income Builder, Inc. 0.84% 14.87M 2.01B
Select Sector SPDR Fund-Health Care 0.81% 14.36M 1.94B
Washington Mutual Investors Fund 0.75% 13.22M 1.78B

ABBV News

  • CollPlant Biotechnologies Launches Redesigned Corporate Website

    03/18 09:00 am

    Benzinga

    Read more
  • My Top 3 Dividend Kings to Buy for March 2026

    03/17 06:32 am

    The Motley Fool

    Read more
  • This Investor Sold $104 Million of Nuvalent Stock Amid Cancer Drug Developer's Nearly 30% Rally

    03/16 08:00 pm

    The Motley Fool

    Read more
  • My 5 Favorite Dividend Stocks to Buy Right Now

    03/15 08:05 am

    The Motley Fool

    Read more
  • Concorde Financial Exits Howard Hughes Holdings, Developer of Large Sun Belt Communities

    03/13 01:16 pm

    The Motley Fool

    Read more
  • The Best Dividend Stocks to Buy and Hold Forever

    03/12 01:30 pm

    The Motley Fool

    Read more
  • AbbVie's Early Obesity Drug Data Shows Up To 10% Weight Loss

    03/09 10:11 am

    Benzinga

    Read more
  • These 3 Cash Flow Machines Provide Stability in Uncertain Markets

    03/06 11:09 am

    Investing.com

    Read more
  • Cytokines Market Global Forecast 2026-2032: Precise Treatments, Strategic Partnerships, and Supply Chain Resilience Fueling the $95+ Billion Market

    03/05 05:44 am

    GlobeNewswire Inc.

    Read more
  • AbbVie Says 55% Of Crohn's Patients Reached Remission With Skyrizi, Bolsters Competitive Positioning Against Johnson & Johnson

    03/02 01:28 pm

    Benzinga

    Read more
  • One in Three Rheumatologists View BMS’ Sotyktu as a Substantial Advance in Psoriatic Arthritis Ahead of March 6 FDA Decision, According to Spherix Global Insights Data

    02/27 01:31 pm

    GlobeNewswire Inc.

    Read more
  • Forgotten Large Caps Are Quietly Outperforming in 2026

    02/27 12:07 pm

    Investing.com

    Read more
  • Advanced Drug Delivery Market to Grow 10.2% Annually Through 2030

    02/25 01:54 pm

    GlobeNewswire Inc.

    Read more
  • Global Ophthalmic Drugs Market Estimated at US$41.88 Billion in 2026; Projected to Grow at 7.9% CAGR Through 2036

    02/25 10:00 am

    GlobeNewswire Inc.

    Read more
  • FDA Approval For AbbVie/AstraZeneca's Combination Treatment Could Set New Standard For Slow Growing Blood Cancer

    02/20 09:02 am

    Benzinga

    Read more
  • AbbVie Declares Quarterly Dividend

    02/19 10:37 am

    Benzinga

    Read more
  • Alzheimer's Therapeutics Market Research Report 2026-2036: Growing Global Burden of Alzheimer's Continues to Drive Demand - Opportunities in Surge in Merger & Acquisitions, Increasing R&D Investments

    02/18 08:00 am

    GlobeNewswire Inc.

    Read more
  • Uterine Fibroid Market Size to Reach USD 9.43 Billion by 2033 with 7.63% CAGR – SNS Insider

    02/16 09:00 am

    GlobeNewswire Inc.

    Read more
  • Lip Augmentation Market Size to Reach USD 17.37 Billion by 2035 with 8.21% CAGR – SNS Insider

    02/16 07:00 am

    GlobeNewswire Inc.

    Read more
  • 1 No-Brainer Dividend Stock to Buy on the Dip

    02/15 06:05 pm

    The Motley Fool

    Read more
  • 2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off

    02/14 09:15 am

    The Motley Fool

    Read more
  • PathAI Expands AISight® Clinical Trials Platform with Launch of AIM-HI™ UC and IBDExplore™ for Standardized Histopathology Endpoints

    02/10 10:00 am

    GlobeNewswire Inc.

    Read more
  • CVS Caremark Replaces Amgen And Eli Lilly's Branded Drugs, Expands Biosimilar Strategy For Weak Bone Disorder

    02/06 02:52 pm

    Benzinga

    Read more
  • AbbVie's Inflammation Drug Humira Slows, But Skyrizi, Rinvoq Drive Revenue Growth

    02/04 01:38 pm

    Benzinga

    Read more
  • Q4 Earnings Summary: Eli Lilly and AbbVie Beat, Uber Mixed

    02/04 12:01 pm

    Investing.com

    Read more
  • 2 Healthcare Dividend Stocks That are Just What the Doctor Ordered

    02/03 06:35 pm

    The Motley Fool

    Read more
  • Better Long-Term Buy: This Emerging Player or the Industry Leader?

    01/30 04:30 pm

    The Motley Fool

    Read more
  • Novo Nordisk Outspends Eli Lilly On Wegovy, Ozempic Ads After Supply Crunch Eases

    01/30 01:57 pm

    Benzinga

    Read more
  • Atopic Dermatitis Market to Reach USD 12.97 Billion by 2034, Growing at 7.75% CAGR

    01/27 11:00 am

    GlobeNewswire Inc.

    Read more
  • Why Revolution Medicines Stock Plummeted by Almost 17% Today

    01/26 08:16 pm

    The Motley Fool

    Read more
  • Revolution Medicines Stock Sinks After Merck Deal Talks Collapse

    01/26 07:01 am

    Benzinga

    Read more
  • Johnson & Johnson Clears the Patent Cliff as 2026 Guidance Resets the Narrative

    01/21 10:43 am

    Investing.com

    Read more
  • Bioconjugation Market Size to Hit USD 14.51 Billion by 2033, Driven by the Increasing Demand for Targeted Therapeutics – SNS Insider

    01/19 12:00 pm

    GlobeNewswire Inc.

    Read more
  • Could Buying This Stock Today Pay Off Big Over the Next 5 Years?

    01/18 08:20 am

    The Motley Fool

    Read more
  • Genmab Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

    01/16 02:30 pm

    GlobeNewswire Inc.

    Read more
  • Systemic Lupus Erythematosus Market to Exhibit Growth at a CAGR of 9.4% During the Forecast Period (2025–2034) Owing to Rising Use of Biologics – Approvals of BENLYSTA and SAPHNELO, Plus a Strong Pipeline | DelveInsight

    01/13 02:00 pm

    GlobeNewswire Inc.

    Read more
  • AbbVie Gets Tariff Relief, Pledges $100 Billion, Lower Prices For Key Medicines

    01/13 09:09 am

    Benzinga

    Read more
  • Merck In Talks To Buy Cancer Drug-Maker Revolution Medicines In A $28 To $32 Billion Deal — Stock Soars Overnight

    01/09 02:52 am

    Benzinga

    Read more
  • Why Revolution Medicines Shares Are Sliding After Hours On Wednesday

    01/08 04:13 am

    Benzinga

    Read more
  • Red Spruce Capital Nets $3.7 Million by Dumping One-Third of BSCR Shares

    01/07 08:05 am

    The Motley Fool

    Read more
  • Buying This Healthcare Stock Could Make You a Millionaire Retiree

    01/03 07:08 am

    The Motley Fool

    Read more
  • Ironwood Finds a New Floor as LINZESS Net Pricing Turns Into a Growth Lever

    01/02 02:30 pm

    Investing.com

    Read more
  • 3 No-Brainer Dividend Stocks to Buy Right Now

    12/30 04:05 pm

    The Motley Fool

    Read more
  • Is AbbVie a Buy, Sell, or Hold in 2026?

    12/27 03:30 pm

    The Motley Fool

    Read more
  • 3 Dividend Growth Stocks Analysts Are Upgrading for 2026

    12/22 10:24 am

    Investing.com

    Read more
  • White House Readies Drug Price Deals With AbbVie, Novartis, Roche

    12/18 11:14 am

    Benzinga

    Read more
  • Want Decades of Passive Income? Buy This ETF and Hold It Forever.

    12/17 03:11 pm

    The Motley Fool

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: